Revenue Breakdown
Composition ()
No data
Revenue Streams
Evolent Health Inc (EVH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Clinical Solutions, accounting for 73.3% of total sales, equivalent to $507.48M. Other significant revenue streams include Evolent Health Services and Intersegment Eliminations. Understanding this composition is critical for investors evaluating how EVH navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Evolent Health Inc maintains a gross margin of 11.14%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2.06%, while the net margin is -91.55%. These profitability ratios, combined with a Return on Equity (ROE) of -81.81%, provide a clear picture of how effectively EVH converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, EVH competes directly with industry leaders such as SUPX and PSFE. With a market capitalization of $362.82M, it holds a significant position in the sector. When comparing efficiency, EVH's gross margin of 11.14% stands against SUPX's 10.16% and PSFE's 41.95%. Such benchmarking helps identify whether Evolent Health Inc is trading at a premium or discount relative to its financial performance.
